Skip to content

Trial Summary

Pertuzumab study in the neoadjuv ant setting for HER2-positive non-metastatic breast cancer in Australia.

Acronym:

PERSIA

ACTRN/NCT /ethics:

Ethics: 163.18

Scientific title:

Sponsor / Cooperative group:

Trial & Patient Characteristics

Cancer TypeBreast
Trial TypeTreatment
PhaseAll phases
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer StageAll stages
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorAlex Scott-Hoy
Emailalex.scott-hoy@sa.gov.au
Phone08 8204 4830
Principal InvestigatorDr Ganessan Kichenadasse
Recruitment StatusRecruiting